Results from a comparison study of molecular vs. non-molecular testing for Clostridium difficile toxin have shown that molecular testing detects 35% to 54% more positive specimens than other methods.
BLACKSBURG, Va., Jan. 23, 2018 /PRNewswire/ -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results